•
Sep 30, 2022

Viridian Therapeutics Q3 2022 Earnings Report

Total Revenue
$1.2M
Previous year: $208K
+474.5%
EPS
-$0.86
Previous year: -$1.25
-31.2%
Gross Profit
-$20.9M
Previous year: -$7.91M
+164.4%
Cash and Equivalents
$344M
Previous year: $139M
+147.9%
Free Cash Flow
-$20.8M
Previous year: -$12.1M
+72.1%
Total Assets
$441M
Previous year: $221M
+99.2%

Viridian Therapeutics

Viridian Therapeutics